Artelo Biosciences (ARTL) awards director 136 stock options at $1.15
Rhea-AI Filing Summary
Artelo Biosciences director Tamara A. Favorito received a grant of stock options covering 136 shares of common stock at an exercise price of $1.15 per share. The options expire on July 17, 2036 and will fully vest, subject to her continuing as a Service Provider, on the earlier of one year after the July 17, 2026 Vesting Commencement Date or the day before the next annual stockholders’ meeting following that date. After this grant, she directly holds 136 stock options.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
FAVORITO TAMARA A
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) F1 | 136 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 136 shares (Direct)
Footnotes (1)
- F1. Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. "Vesting Commencement Date" shall mean July 17, 2026.
Key Figures
Stock options granted: 136 shares
Exercise price: $1.1500 per share
Expiration date: July 17, 2036
+2 more
5 metrics
Stock options granted
136 shares
Stock Option (right to buy) for common stock
Exercise price
$1.1500 per share
Conversion or exercise price of the option
Expiration date
July 17, 2036
Option expiration date
Underlying shares
136 shares
Common stock underlying the option
Vesting Commencement Date
July 17, 2026
Date from which vesting schedule is measured
Key Terms
Stock Option (right to buy), Vesting Commencement Date, Service Provider
3 terms
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
Vesting Commencement Date financial
""Vesting Commencement Date" shall mean July 17, 2026."
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
Service Provider financial
"Subject to the Reporting Person continuing to be a Service Provider"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What stock options were granted to Tamara A. Favorito at ARTL?
Tamara A. Favorito was granted stock options for 136 shares of Artelo Biosciences common stock at an exercise price of $1.15 per share. These options expire on July 17, 2036 and are reported as directly owned following the grant.
How do the new ARTL options for Tamara A. Favorito vest?
The options vest 100% if she continues as a Service Provider until the vesting date. Vesting occurs on the earlier of one year after the July 17, 2026 Vesting Commencement Date or the day before the next annual stockholders’ meeting following that date.
What is the exercise price and expiration for Tamara Favorito’s ARTL options?
The granted options have an exercise price of $1.15 per share and an expiration date of July 17, 2036. She can purchase up to 136 shares of Artelo Biosciences common stock at that price once the options are vested.
How many ARTL options does Tamara Favorito hold after this grant?
Following this reported transaction, Tamara A. Favorito directly holds 136 stock options for Artelo Biosciences common stock. Each option relates to one underlying share, giving rights to purchase 136 shares in total once vested and exercised.
Is Tamara Favorito’s ARTL option vesting dependent on continued service?
Yes. The footnote states vesting is conditioned on her continuing to be a Service Provider under the company’s plan through the applicable vesting date. Without continued service, the 100% cliff vesting described would not be satisfied.